h1

h2

h3

h4

h5
h6


001     851153
005     20250819150629.0
024 7 _ |2 HSB
|a eva469458
024 7 _ |2 ISSN
|a 2234-943X
024 7 _ |2 SCOPUS
|a SCOPUS:2-s2.0-85114300972
024 7 _ |2 WOS
|a WOS:000693616900001
024 7 _ |2 datacite_doi
|a 10.18154/RWTH-CONV-248241
024 7 _ |2 doi
|a 10.3389/fonc.2021.729207
024 7 _ |2 pmid
|a pmid:34490122
037 _ _ |a RWTH-CONV-248241
041 _ _ |a English
100 1 _ |a Rolles, Benjamin
|b 0
245 _ _ |a Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy
|h online
260 _ _ |a Lausanne
|b Frontiers Media
|c 2021
300 _ _ |a 1-9
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
536 _ _ |0 G:(GEPRIS)403224013
|a SFB 1382 - SFB 1382: Die Darm-Leber-Achse - Funktionelle Zusammenhänge und therapeutische Strategien (403224013)
|c 403224013
|x 0
591 _ _ |a Germany
700 1 _ |a Gorgulho, Joao
|b 1
700 1 _ |a Tometten, Mareike
|b 2
700 1 _ |a Roderburg, Christoph
|b 3
700 1 _ |a Vieri, Margherita
|b 4
700 1 _ |a Abels, Anne
|b 5
700 1 _ |a Vucur, Mihael
|b 6
700 1 _ |a Heymann, Felix
|b 7
700 1 _ |0 P:(DE-82)001476
|a Tacke, Frank
|b 8
700 1 _ |0 P:(DE-82)IDM06025
|a Brümmendorf, Tim Henrik
|b 9
700 1 _ |0 P:(DE-82)016418
|a Lüdde, Tom
|b 10
|e Corresponding author
700 1 _ |a Beier, Fabian
|b 11
700 1 _ |a Loosen, Sven H.
|b 12
773 _ _ |0 PERI:(DE-600)2649216-7
|a 10.3389/fonc.2021.729207
|p 729207
|t Frontiers in oncology
|v 11
|x 2234-943X
856 4 _ |u https://publications.rwth-aachen.de/record/851153/files/851153.pdf
|y OpenAccess
909 C O |o oai:publications.rwth-aachen.de:851153
|p VDB
|p dnbdelivery
|p driver
|p open_access
|p openaire
914 1 _ |y 2021
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
|a Creative Commons Attribution CC BY 4.0
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b DOAJ : Blind peer review
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b FRONT ONCOL : 2019
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0320
|2 StatID
|a DBCoverage
|b PubMed Central
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2022-11-08
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2022-11-08
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
|d 2021-01-27
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
|b FRONT ONCOL : 2021
|d 2022-11-08
920 1 _ |0 I:(DE-82)531040-2_20140620
|k 531040-2
|l Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)
|x 0
970 _ _ |a eva469458
980 1 _ |a FullTexts
980 _ _ |a I:(DE-82)531040-2_20140620
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a journal


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21